Tinnitus pipeline therapeutics constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by Companies and remaining by the Universities/Institutes. Our latest report Tinnitus - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Tinnitus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Tinnitus is a condition characterized by ringing, swishing, or other noises that originating in the ear or head. Causes of tinnitus are age-related hearing loss, exposure to loud noises, earwax blockage in the ear canal, smoking and abnormal bone growth in the ear. Symptoms include ringing; buzzing, roaring, clicking, whistling, hissing, or squealing, noises may appear low or high in pitch. The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 3 and 5 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.
Furthermore, this report also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects.
Key Topics Covered:
- Tinnitus Overview
- Therapeutics Development
- Pipeline Products for Tinnitus - Overview
- Pipeline Products for Tinnitus - Comparative Analysis
- Tinnitus - Therapeutics under Development by Companies
- Tinnitus - Therapeutics under Investigation by Universities/Institutes
- Tinnitus Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Tinnitus - Products under Development by Companies
- Tinnitus - Products under Investigation by Universities/Institutes
- Tinnitus - Companies Involved in Therapeutics Development
- AudioCure Pharma GmbH
- Auris Medical Holding AG
- Knopp Biosciences LLC
- Merz Pharma GmbH & Co. KgaA
- Otonomy, Inc.
- SciFluor Life Sciences, LLC
Sound Pharmaceuticals, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/zkpr6t/tinnitus